Novo Nordisk
NVO
#15
Rank
ยฃ455.54 B
Marketcap
ยฃ102.77
Share price
2.14%
Change (1 day)
36.12%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Net assets

Net assets on the balance sheet as of June 2024 : ยฃ12.34 B

According to Novo Nordisk's latest financial reports the company has ยฃ12.34 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novo Nordisk - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$ยฃ12.38 B24.65%
2022-12-31$ยฃ9.93 B24.87%
2021-12-31$ยฃ7.95 B3.79%
2020-12-31$ยฃ7.66 B17.84%
2019-12-31$ยฃ6.50 B4.54%
2018-12-31$ยฃ6.22 B4.76%
2017-12-31$ยฃ5.94 B14.39%
2016-12-31$ยฃ5.19 B11.95%
2015-12-31$ยฃ4.63 B9.75%
2014-12-31$ยฃ4.22 B-11.41%
2013-12-31$ยฃ4.77 B7.11%
2012-12-31$ยฃ4.45 B6.15%
2011-12-31$ยฃ4.19 B-2.11%
2010-12-31$ยฃ4.28 B-0.01%
2009-12-31$ยฃ4.28 B-0.39%
2008-12-31$ยฃ4.30 B36.31%
2007-12-31$ยฃ3.15 B15.8%
2006-12-31$ยฃ2.72 B7.65%
2005-12-31$ยฃ2.53 B0.03%
2004-12-31$ยฃ2.53 B5%
2003-12-31$ยฃ2.41 B13.76%
2002-12-31$ยฃ2.12 B3.09%
2001-12-31$ยฃ2.05 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
ยฃ67.03 B 443.14%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ10.38 B-15.82%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ13.00 B 5.38%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ59.62 B 383.11%๐Ÿ‡ซ๐Ÿ‡ท France